MAVIRET
As listed in the register: MAVIRET 100 mg/40 mg, comprimé pelliculé
100 mg + 40 mg · comprimé pelliculé
- Prescription only
- Active substance
- Glécaprévir + Pibrentasvir
- Made by
- ABBVIE DEUTSCHLAND (ALLEMAGNE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | ABBVIE DEUTSCHLAND (ALLEMAGNE) |
|---|---|
| Active substance | Glécaprévir + Pibrentasvir |
| Strength | 100 mg + 40 mg |
| Form | comprimé pelliculé |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/17/1213 |
| Name in the register | MAVIRET 100 mg/40 mg, comprimé pelliculé |
| Packs | 4 plaquette(s) PVC polyéthylène polychlortrifluoroéthylène aluminium de 21 comprimé(s) |
| CIS | 63052124 |
| CIP13 | 3400930108765 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- comprimé pelliculé1 products
- 100 mg + 40 mg
- granulés enrobé1 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.